Literature DB >> 21710121

Outcomes of post-cataract surgery endophthalmitis referred to a tertiary center from local hospitals in the south of China.

Y Ding1, M Lin, H Liu, W Zhang, L Wang, Y Li.   

Abstract

BACKGROUND: Endophthalmitis after cataract surgery is an uncommon but devastating complication. Prophylactic intracameral injection of cefuroxime 1 mg at the end of surgery decreases the incidence five-fold. The visual outcome can be good (53% of cases having a visual acuity [VA] of better than 20/40) if treatment is initiated rapidly and follows the Endophthalmitis Vitrectomy Study (EVS) guidelines; but even with the best treatment, some patients end up with a poor visual outcome. Previous studies on postoperative endophthalmitis mainly focus on the cases performed in metropolitan tertiary hospitals; however, little information is available on the cases performed in local hospitals in rural areas.
METHODS: We retrospectively reviewed the medical records of patients with acute endophthalmitis following cataract surgery, which were performed in local hospitals and later treated at the Zhongshan Ophthalmic Center between 1 January 1998 and 31 December 2009. Details of each case, including the interval from symptoms to presentation, initial treatment in local hospitals, microorganisms isolated, treatment, and visual outcome, were recorded. Cross-tabulations were conducted in order to identify the prognostic factors of final visual outcome.
RESULTS: Forty-six patients referred from 36 local hospitals and later treated at the Zhongshan Ophthalmic Center were reviewed over the audit period. Most of these cases occurred in April. Gram-positive bacteria were the predominant etiology, with fungal infection accounting for 15%. Even though 54% of patients had symptoms within 3 days post-cataract surgery, they did not present to a tertiary center until a mean of 10 days. The main initial treatment in local hospitals is systemic antibiotics, instead of the intravitreal injection of antibiotics. A high proportion of cases (27/46) received immediate pars plana vitrectomy (PPV) in the tertiary center, and the antibiotic used for intravitreal injection was mainly tobramycin. The final visual outcome was poor, with only three cases having a VA ≥20/40.
CONCLUSION: A relatively high rate of fungal endophthalmitis suggests that sterilization patterns in local hospitals should be further revised. A delayed presentation, inappropriate treatment procedures, poor presenting VA, and causative organism virulence may account for the unfavorable visual outcome in this study.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21710121     DOI: 10.1007/s15010-011-0138-0

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  37 in total

1.  Acute inflammation and loss of retinal architecture and function during experimental Bacillus endophthalmitis.

Authors:  Raniyah T Ramadan; Raul Ramirez; Billy D Novosad; Michelle C Callegan
Journal:  Curr Eye Res       Date:  2006-11       Impact factor: 2.424

Review 2.  Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project.

Authors:  Dale W Bratzler; Peter M Houck
Journal:  Am J Surg       Date:  2005-04       Impact factor: 2.565

Review 3.  Postoperative endophthalmitis.

Authors:  Nick Mamalis; Laura Kearsley; Eric Brinton
Journal:  Curr Opin Ophthalmol       Date:  2002-02       Impact factor: 3.761

4.  Microbiologic spectrum and susceptibility of isolates: part I. Postoperative endophthalmitis. Endophthalmitis Research Group.

Authors:  D Y Kunimoto; T Das; S Sharma; S Jalali; A B Majji; U Gopinathan; S Athmanathan; T N Rao
Journal:  Am J Ophthalmol       Date:  1999-08       Impact factor: 5.258

5.  Acute endophthalmitis after cataract surgery at a referral centre in Northern Taiwan: review of the causative organisms, antibiotic susceptibility, and clinical features.

Authors:  J-H Cheng; Y-H Chang; C-L Chen; Y-H Chen; D-W Lu; J-T Chen
Journal:  Eye (Lond)       Date:  2010-04-09       Impact factor: 3.775

6.  Spectrum of aetiological agents of postoperative endophthalmitis and antibiotic susceptibility of bacterial isolates.

Authors:  A R Anand; K L Therese; H N Madhavan
Journal:  Indian J Ophthalmol       Date:  2000-06       Impact factor: 1.848

7.  Acute-onset endophthalmitis after cataract surgery: success of initial therapy, visual outcomes, and related factors.

Authors:  Tugrul Altan; Nur Acar; Ziya Kapran; Yaprak Banu Unver; Serap Yurttaser; Yaşar Küçüksümer; Ilker Eser
Journal:  Retina       Date:  2009-05       Impact factor: 4.256

8.  Acute endophthalmitis after cataract surgery: 250 consecutive cases treated at a tertiary referral center in the Netherlands.

Authors:  Benjamin J Pijl; Thomas Theelen; Maurits A D Tilanus; Rob Rentenaar; Niels Crama
Journal:  Am J Ophthalmol       Date:  2010-01-06       Impact factor: 5.258

9.  Surveillance of endophthalmitis following cataract surgery in the UK.

Authors:  S Kamalarajah; G Silvestri; N Sharma; A Khan; B Foot; R Ling; G Cran; R Best
Journal:  Eye (Lond)       Date:  2004-06       Impact factor: 3.775

10.  Acute-onset nosocomial endophthalmitis after cataract surgery: incidence, clinical features, causative organisms, and visual outcomes.

Authors:  Hani S Al-Mezaine; Dustan Kangave; Abdullah Al-Assiri; Ali A Al-Rajhi
Journal:  J Cataract Refract Surg       Date:  2009-04       Impact factor: 3.351

View more
  12 in total

1.  Risk factors for endophthalmitis following cataract surgery-our experience at a tertiary eye care centre in India.

Authors:  Rohit C Khanna; Vanita Pathak Ray; Madhavi Latha; Sandra D Cassard; Annie Mathai; Garudadri C Sekhar
Journal:  Int J Ophthalmol       Date:  2015-12-18       Impact factor: 1.779

2.  Characteristics of Endophthalmitis after Cataract Surgery in the United States Medicare Population.

Authors:  Emily W Gower; Lisa J Keay; Dianne E Stare; Pallavi Arora; Sandra D Cassard; Ashley Behrens; James M Tielsch; Oliver D Schein
Journal:  Ophthalmology       Date:  2015-06-02       Impact factor: 12.079

Review 3.  Age-related cataracts: Role of unfolded protein response, Ca2+ mobilization, epigenetic DNA modifications, and loss of Nrf2/Keap1 dependent cytoprotection.

Authors:  Palsamy Periyasamy; Toshimichi Shinohara
Journal:  Prog Retin Eye Res       Date:  2017-08-31       Impact factor: 21.198

4.  Incidence and Determinants of Endophthalmitis within 6 Months of Surgeries over a 2-Year Period at King Khaled Eye Specialist Hospital, Saudi Arabia: A Review.

Authors:  Rajiv Khandekar; Saeed Al-Motowa; Hind M Alkatan; Mohammed Karaoui; Anne Ortiz
Journal:  Middle East Afr J Ophthalmol       Date:  2015 Apr-Jun

5.  Post-clear corneal phacoemulsification endophthalmitis: profile and management outcomes at a tertiary eye care center in western India.

Authors:  Aditya S Kelkar; Jai A Kelkar; Prajakta M Barve; Aishwarya Mulay; Shubhangi Sharma; Winfried Amoaku
Journal:  J Ophthalmic Inflamm Infect       Date:  2016-11-28

6.  Treatment outcomes of post cataract surgery endophthalmitis in a tertiary referral center in Iran.

Authors:  Hamidreza Torabi; Seyed-Ali Tabatabai; Alireza Khodabande
Journal:  J Curr Ophthalmol       Date:  2018-01-06

7.  Long-Term Effect of Silicone Oil Tamponade for Postoperative and Posttraumatic Bacterial Endophthalmitis.

Authors:  Yong Koo Kang; Jae Pil Shin; Han Sang Park
Journal:  J Ophthalmol       Date:  2021-02-01       Impact factor: 1.909

8.  Recurrent endophthalmitis after trabeculectomy for glaucoma: importance of timely filtering bleb coverage for the conjunctiva.

Authors:  Carl-Ludwig Schönfeld
Journal:  Case Rep Ophthalmol       Date:  2012-10-23

9.  Cohort study of intracameral moxifloxacin in postoperative endophthalmitis prophylaxis.

Authors:  Virgilio Galvis; Alejandro Tello; Mary Alejandra Sánchez; Paul Anthony Camacho
Journal:  Ophthalmol Eye Dis       Date:  2014-01-16

10.  Bacterial Spectrum and Antibiotic Resistance Patterns of Ocular Infection: Differences between External and Intraocular Diseases.

Authors:  Nan Wang; Qian Yang; Yiwei Tan; Liping Lin; Qiang Huang; Kaili Wu
Journal:  J Ophthalmol       Date:  2015-10-21       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.